藥師應(yīng)該關(guān)注“藥品說(shuō)明書之外的用法”doc-資料下載頁(yè)
2025-07-15 06:53本頁(yè)面
【正文】 KJ, Viera AJ, Parman CL. Offlabel applications for SSRIs. Am Fam Physician. 2003 Aug 1。 68(3):498~504.[18] Lim HY,JooHJ,ChoiJH,et expression of cy?鄄clooxygenase2 protein in human gastric carcinoma [J] Clin Can Res 2000,6(2):519~525[19] Zimmermann KC,Sarbia M,Weber AA,et al. Cyclooxyge?鄄nase2 expression in human esophageal carcinoma [J] Cancer Res,1999,59(5):198~204[20] Jaime LM,Kathleen ML,Alane TK,et al. Antiangisgenic and antitumor activeties of cyclooxygenase2 inhibitors [J] Cancer Res,2000,60:1360~1311[21] Greenwood J, Steinman L, Zamvil SS. Statin therapy and autoimmune disease: from protein prenylation to im?鄄munomodulation. Nat Rev Immunol. 2006 May。 6(5):358~370.[22] Jadhav SB, Jain GK. Statins and osteoporosis: new role for old drugs. J Pharm Pharmacol. 2006 Jan。 58(1):3~18.[23] Suzuki T, Izumi S, Awaji H, et al. Preservation of tubal function following methotrexate treatment for ectopic pregnancy. Tokai J Exp Clin Med. 2004 Dec。 29(4):183~189.[24] Periti E, Comparetto C, Villanucci A, et al. The use of intravenous methotrexate in the treatment of ectopic pregnancy. J Chemother. 2004 Apr。 16(2):211~215.[25] Brown CG, Werman HA, Davis EA, et al. The effects of graded doses of epinephrine on regional myocardial blood flow during cardiopulmonary resuscitation in swine. Cir?鄄culation. 1987 Feb。 75(2):491~497.[26] Bavdekar SB, Gogtay NJ. Unlicensed and offlabel drug use in children. J Postgrad Med. 2005 OctDec。 51(4):249~252.[27] Neubert A, Dormann H, Weiss J, et al. The impact of un?鄄licensed and offlabel drug use on adverse drug reactions in paediatric patients. Drug saf. 2004。 27(13):1059~1067.[28] Picard D, Carvalho P, Bonnavia C, et al. Assessment offlabel prescribing in Dermatology. Ann Dermatol Venere?鄄ol. 2003 May。 130(5):507~510.[29] Schirm E, Tobi H, de Jongvan den Berg LT. Risk factors for unlicensed and offlabel drug use in children outside the hospital. Pediatrics. 2003 Feb。 111(2):291~295.[30] [No authors listed]. ASHP statement on the use of medica?鄄tions for unlabeled uses. Am J Hosp Pharm. 1992 Aug。 49(8):2006~2008.[31] Boos J. Off label uselabel off use? Ann Oncol. 2003 Jan。 14(1):1~5.15 / 15
高考資料相關(guān)推薦
鄂ICP備17016276號(hào)-1